Kings Path Partners’s Recursion Pharmaceuticals RXRX Stock Holding History

Kings Path Partners’s Portfolio RXRX Stock Details RXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$10.1K	Hold
2025 Q1	$10.6K	Hold
2024 Q4	$13.5K	Buy
2024 Q3	$6.59K	Buy